Users of alternative remedies tend to refuse cancer treatments, with increased mortality

{Taj Pharma} Users of alternative remedies tend to refuse cancer treatments, with increased mortality

Cancer patients who use complementary medicine tend to refuse effective treatments more often than non users, and this reflects on increased mortality: this is the conclusion of an observational study just published on Jama Oncology, that involved patients with four common cancers (breast, prostate, lung or colorectal).

Skyler Johnson and colleagues from the Yale School of Medicine in New Haven, Connecticut (Usa) selected – from among 1.9 million patients in the National Cancer Database – a group of 258 patients who used complementary medicine and were diagnosed between 2004 and 2013 with non‐metastatic breast, prostate, lung or colorectal cancer , and compared them with a group of 1 032 similar patients who did not use alternative remedies. They monitored the use of “unproven cancer treatments administered by nonmedical personnel” in addition to at least one conventional cancer therapy such as surgery, radiotherapy, chemotherapy or hormone therapy and measured overall survival, adherence to treatment and how they relate to patient characteristics.

“We found that, among patients who were receiving at least one conventional cancer treatment (CCT) modality, patients who chose complementary medicine (CM) were more likely to refuse at least one component of CCT and had a higher risk of death than patients who did not use complementary medicine. After adjusting for delays and refusal of conventional cancer treatment, complementary medicine was not associated with an increased risk of death” the researchers conclude. “We believe our work to be critically important to patients considering complementary medicine — a group that likely includes most patients with cancer. Given the hesitance on behalf of patients to disclose nonmedical therapy to their clinicians, health care professionals need to be proactive in discussing complementary medicine and adherence to conventional medicine treatment with their patients. For patients with curable cancers who are inclined to pursue complementary treatment methods, timely adherence to all recommended conventional therapies should be strongly advised”.

About – Taj Oncology

Taj Oncology’s vision is to become a world class player in oncology through excellence in innovation, discovery of new manufacturing processes / drug delivery mechanisms and consistently high quality of production.

We commenced operations in 1994 with the inauguration of our ultra-modern facility for the production of generics and formulations for oncology and other therapeutic applications. We are one of the pioneers in India in lyophilization.

We identified, very early, the need for achieving self – sufficiency in formulations as well as in Active Pharmaceutical Ingredients (APIs) , and our achievements reflect this focus. We launched our (APIs) in year 1994 & now have to our credit a number of new manufacturing processes & drug delivery mechanisms.

We have a manufacturing plant located at Tarapur, Thane in Maharashtra State. This facility meets the current Good Manufacturing Practices norms as laid down by the World Health Organization.

Our marketing spans domestic and overseas operations. With a network across the Indian sub-continent and market penetration in several countries across four continents, we are on our way to meeting our target of reaching out to cancer patients, worldwide.

Taj Pharmaceuticals, is a generics pharmaceuticals company with product range exceeding 4600 compositions under all therapeutic categories

Taj Pharmaceuticals Limited manufactures and distributes medicines. The company’s products include prescription solutions, lifesaving drugs, anti-cancer drugs, veterinary products, consumer brands, and CNS drugs. It focuses on medicines of anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases. Taj Pharmaceuticals India Business is headquartered in Mumbai, India.

Taj Pharmaceuticals is the global leader in generics and one of the India’s top ten pharmaceutical companies. Taj Pharma India play a leading role in therapeutic areas such as cancer, virology and transplantation. The combined strengths of Taj Pharma generics and pharmaceuticals businesses, coupled with expertise in the emerging genetic sciences, equip us to develop integrated healthcare solutions and therapeutic approaches tailored to individual patients’ needs. Taj Pharmaceutical’s products and services address the entire healthcare spectrum, from screening for genetic risk factors, to preventing, diagnosing and treating disease, and monitoring the treatment response.

Taj Pharma India delivers a unique contribution to better healthcare. Taj Pharma India aim to reduce suffering and improve health and quality of life of people all around the world. At Taj Pharmaceuticals, Taj Pharma India have pursued this mission with patience, dedication, imagination and skill, for over a century. Taj Pharma vision is to develop targeted medicines and diagnostic tools that combine to offer patients, physicians and payers better, safer, more cost-effective healthcare.

Once again, welcome to Taj Pharmaceuticals, a great company that is translating a great vision into reality – We Innovate Generics Healthcare.

Taj Pharmaceuticals Limited is committed to earning the trust of doctors, patients and customers every day. Taj Pharma colleagues worldwide believe that trust is not easily granted, and that is the reason Taj Pharma India focus each day on becoming a champion for Taj Pharma stakeholders.

During the past ten years, Taj Pharmaceuticals Group has been building a new kind of health care company. Throughout Taj Pharma Group (India), there’s a desire to build long-term relationships with Taj Pharma stakeholders based on mutual confidence. This is evident in many ways. Taj Pharma scientists are earning trust through the discovery and development of innovative, science-based medicines and services that improve the health and overall well-being of people around the world. Taj Pharma sales professionals, marketing teams, colleagues working at Taj Pharma plants and others throughout the organization at all levels of responsibility take each day as a fresh opportunity to earn trust.

All of this takes hard work, sharp execution, integrity and transparency on the part of Taj Pharmaceuticals Group colleagues. Taj Pharma global team is working to sustain and expand innovative new treatments. Taj Pharma India’re determined to do Taj Pharma part to increase access to better health care for all people. And, Taj Pharma India is focused on becoming the best in three key strategic areas: people, products and processes.

Taj Pharma India’re beginning to see the results of Taj Pharma efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. From Taj Pharma perspective as a health care company, that means helping people around the world live better and live longer.The product range includes major generic drugs under therapeutic category such as anti-cancer drugs, CNS drugs; Key category of products includes generic medicines for anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation and common diseases.